The results showed no statistically significant differences in the expression levels of MINDY1 and PD-L1 across different ages, sex, HBsAg, AFP, ALT, tumor size, BCLC staging, tumor number, cirrhosis, portal vein tumor thrombi, microvascular invasion, and other basic conditions (P > 0.05) (Table 2). This evidence concerns the gene MINDY1 and neoplasm.